Ohio State biotech spinoff Entrada raises $59M to tackle deadly disease with no other treatment
December 19, 2018 at 17:03 PM EST
Entrada Therapeutics is launching in Boston with a $59M VC round, using science developed by Ohio State University professor and company co-founder Dehua Pei to deliver treatment to previously un-druggable targets in a cell's mitochondrion.
